{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:48:40Z","timestamp":1760986120824,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective method for the treatment of refractory and relapsed acute leukemia, and the preconditioning methods before transplantationis one of the important factors affecting the survival of patients. Radiotherapy combined with chemotherapy is the most commonly used preconditioning method before transplantation. This study evaluated the safety and efficacy of total bone marrow combined with total lymphatic irradiation as a preconditioning method before hematopoietic stem cell transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Seventeen patients with acute leukemia who were admitted to our center from 2016 to 2020 were selected. The median age was 17 years (8-35). The target area for TMLI includes the total bone marrow and total lymphatic space, and the organs at risk include the lens, lungs, kidneys, intestine, heart, and liver. The patients received a total bone marrow and lymphatic irradiation preconditioning regimen, the related acute adverse reactions were graded, and the prognosis of the patients after transplantation was observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During patient preconditioning, only grade 1-2 toxicity was observed, and grade 3-4 toxicity did not occur. Except for one patient whose platelets were not engrafted, all the other patients were successfully transplanted. The median time of neutrophil implantation was 14\u00a0d (9-15\u00a0d), and the median time of platelet implantation was 14\u00a0d (13-21\u00a0d). With a median follow-up of 9 months (2-48), 4 relapses occurred, 3 died, and 10 leukemia patients survived and were disease-free. One-year overall survival was 69.8%, cumulative recurrence was 19.5%, disease-free-survival was 54.2%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The Allo-HSCT pretreatment regimen of total bone marrow combined with total lymphatic irradiation is safe and effective in the treatment of malignant hematological diseases. Total bone marrow combined with total lymphatic irradiation may completely replace total body irradiation, and the clinically observed incidence of acute toxicity is not high.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.936985","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T05:24:20Z","timestamp":1660195460000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical study of total bone marrow combined with total lymphatic irradiation pretreatment based on tomotherapy in hematopoietic stem cell transplantation of acute leukemia"],"prefix":"10.3389","volume":"12","author":[{"given":"Fanyang","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaipeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lele","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Pi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntong","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuexin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.094284","article-title":"Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN subcommittee of the chronic malignancies working party of the e","volume":"99","author":"Lussana","year":"2014","journal-title":"Haematologica"},{"key":"B2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3390\/jcm8050569","article-title":"Perspectives on the use of a medium-dose etoposide, cyclophosphamide, and total body irradiation conditioning regimen in allogeneic hematopoietic stem cell transplantation: The Japanese experience from 1993 to present","volume":"8","author":"Lmamura","year":"2019","journal-title":"J Clin Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00066-009-1008-x","article-title":"Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies","author":"Ricardi","year":"2009","journal-title":"Strahlenther  Onkol Organ  Deutschen Rontgengesellschaft"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(99)00178-4","article-title":"Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation","volume":"54","author":"Buchali","year":"2000","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"B5","article-title":"Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission","volume":"169","author":"Inoue","year":"1993","journal-title":"Strahlenther  Onkol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.07.1854","article-title":"Impact of total body irradiation technique on interstitial pneumonitis and clinical outcomes of 623 patients undergoing hematopoietic cell transplantation for ALL: 25 years at the university of Minnesota","volume":"69","author":"Tomblyn","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-8-92","article-title":"Total body irradiation (TBI) using helical tomotherapy in children and young adults undergoing stem cell transplantation","volume":"8","author":"Gruen","year":"2013","journal-title":"Radiat Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2019.03.032","article-title":"Implementing safe and robust total marrow irradiation using helical tomotherapy\u2013 a practical guide","volume":"60","author":"Haraldsson","year":"2019","journal-title":"PhysicaMedica"},{"key":"B9","article-title":"Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia","volume":"21","author":"Pjycw","year":"2020","journal-title":"Lancet Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.10.026","article-title":"Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation","volume":"12","author":"Wong","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.08.010","article-title":"Radiation related toxicities using organ sparing total marrow irradiation transplant conditioning regimens","volume":"105","author":"Shinde","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-009-2022-8","article-title":"Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT)","volume":"185","author":"Gerstein","year":"2009","journal-title":"Strahlenther  Onkol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.10.047","article-title":"Image-guided total marrow and total lymphatic irradiation using helical tomotherapy","volume":"67","author":"Schultheiss","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canrad.2017.06.014","article-title":"Total body irradiation using helical tomotherapy\u00ae: Treatment technique, dosimetric results and initial clinical experience","volume":"22","author":"Sarradin","year":"2018","journal-title":"Cancer Radiother"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.04.071","article-title":"Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation","volume":"73","author":"Wong","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijrobp.2014.01.036","article-title":"Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation","volume":"89","author":"Kim","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.03.033","article-title":"Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"85","author":"Wong","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2017.07.018","article-title":"Early assessment of dosimetric and biological differences of total marrow irradiation versus total body irradiation in rodents","volume":"124","author":"Hui","year":"2017","journal-title":"Radiother Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-288357","article-title":"Phase 1\/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies","author":"Rosenthal","year":"2010","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(03)00108-3","article-title":"Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells","volume":"9","author":"Lan","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.12.012","article-title":"Mycophenolate mofetil vs. methotrexate for the prevention of graft-versus-host-disease - systematic review and meta-analysis","volume":"38","author":"Ram","year":"2014","journal-title":"Leuk Res -Oxf-"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(15)41625-1","article-title":"EP-1633: Analysis of dose-volume histogram parameters on prediction esophageal toxicity in radiotherapy for lung tumors","volume":"115","author":"Fita","year":"2015","journal-title":"Radiother Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2020.00528","article-title":"Total marrow and lymphoid irradiation with helical tomotherapy: A practical implementation report","volume":"38","author":"Chilukuri","year":"2020","journal-title":"Radiat Oncol J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2018.01.011","article-title":"Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: A review","volume":"123","author":"Paix","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.04.002","article-title":"Dose escalation of total marrow irradiation in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Hui","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.936985\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T10:46:33Z","timestamp":1660646793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.936985\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":26,"alternative-id":["10.3389\/fonc.2022.936985"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.936985","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"article-number":"936985"}}